Secondary endothelial dysfunction: hypertension and heart failure

J Mol Cell Cardiol. 1999 Jan;31(1):39-49. doi: 10.1006/jmcc.1998.0842.

Abstract

The endothelium is a major regulator of vascular tone, releasing vasoactive substances such as endothelium-derived nitric oxide (EDRF), endothelium-derived hyperpolarizing factor(s), cycloxygenase metabolites, endothelin and other endothelium-derived contracting factors (EDCF). In a number of cardiovascular pathologies, such as hypertension or heart failure, the balance in the endothelial production of vasodilating and vasoconstricting mediators is altered. The resulting apparent decrease in endothelium-dependent relaxations is termed 'endothelial dysfunction'. In hypertensive patients and in animal models of hypertension, endothelium-dependent relaxations are impaired. However, this endothelial dysfunction presents different characteristics depending on the model studied. In Dahl-salt-sensitive rats, the decrease in endothelium-dependent relaxations is associated with impaired constitutive nitric oxide synthase activity. The presence of an endogenous nitric oxide synthase inhibitor and a decreased response of vascular smooth muscle to the mediator may contribute also to the dysfunction observed in this model. In other animal models of hypertension (such as spontaneous hypertension). the contribution of the L-arginine nitric oxide pathway to endothelium-dependent responses appears normal or impaired despite reports of increased nitric oxide synthase activity or expression. In large arteries from SHR, endothelium-dependent relaxations are impaired mainly because of the concomitant augmented release of endoperoxides activating thromboxane-endoperoxide receptors. Superoxide anions may also play a role in some models, but only in the early phase of the disease: whether or not these species contribute to further development of endothelial dysfunction or to increases in blood pressure remains to be examined. The endothelial dysfunction observed in hypertension is likely to be a consequence of high blood pressure. but it could facilitate the maintenance of elevated peripheral resistance at a later stage in the disease and favour the occurrence of complications, such as atherosclerosis.

Publication types

  • Review

MeSH terms

  • Acetylcholine / pharmacology
  • Acetylcholine / physiology
  • Animals
  • Biological Factors / physiology
  • Dose-Response Relationship, Drug
  • Endothelin-1 / physiology
  • Endothelium, Vascular / physiopathology*
  • Heart Failure / physiopathology*
  • Humans
  • Hypertension / physiopathology*
  • Models, Biological
  • Nitric Oxide / biosynthesis
  • Nitric Oxide Synthase / physiology
  • Rats
  • Reactive Oxygen Species / metabolism

Substances

  • Biological Factors
  • Endothelin-1
  • Reactive Oxygen Species
  • endothelium-dependent hyperpolarization factor
  • Nitric Oxide
  • Nitric Oxide Synthase
  • Acetylcholine